Talimogene Laherparepvec (T-Vec) In Combination (Combo) With Ipilimumab (Ipi) Versus Ipi Alone For Advanced Melanoma: 3-Year Landmark Analysis Of A Randomized, Open-Label, Phase Ii Trial J. A. Chesney,I. Puzanov,F. Collichio,P. Singh,M. Milhem,J. Glaspy,O. Hamid,M. I. Ross,P. Friedlander, C. Garbe, T. Logan, A. Hauschild, C. Lebbe, M. Yi,A. Sharma,J. M. MehnertANNALS OF ONCOLOGY(2019)引用 9|浏览90暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络